The World Health Organization is pausing clinical trials of hydroxychloroquine as a possible treatment for the novel coronavirus COVID-19.<br />According to Business Insider, the WHO's steering committee of the study met over the weekend.<br />They agreed to suspend enrollment while gathering data about the safety and efficacy of the drug.<br />Hydroxychloroquine is commonly used to treat malaria and lupus, among other conditions.<br />The study was part of the "Solidarity" trial launched by the WHO, studying four different treatment options for COVID-19.
